Healthcare

Our expertise in therapeutics and diagnostics, spanning our Chemistry and Biotech groups, is widely regarded as the best in Europe. We advise some of the world’s leading biopharmaceutical and pharmaceutical companies on their most important projects, working across the entire lifecycle of IP work. We excel in strategic prosecution on marketed products, and EPO opposition defence and enforcement work for originators against generic competition, particularly in the case of multi-opponent proceedings. The Chemistry group also has a strong reputation for consumer product work. 

Our Engineering and Tech groups have unrivalled experience in handling strategically important medical device work, including drafting, prosecution, EPO opposition, defence and litigation. The group represents a huge range of medical technology, ranging from surgical devices to medical lasers, from contact lenses to drug delivery systems.   

Our Dispute Resolution and Transaction groups are recognised in the market for handling highly complex and technical disputes and transactions cases across the healthcare domain, with expertise in pharma and biotech licensing and litigation, including SPCs, as well as regulatory approval and pan-European medical device disputes matters. 

Our Trade Marks group skilfully navigates the long and complex process of branding a new pharmaceutical, including trade mark clearance, checks of generic names (INNS) and pre-existing pharmaceutical names, and advises on enforcement strategies, including in relation to counterfeits and parallel imports.